Current biopsy techniques and clinical disease assessment of prostate cancer frequently fail to accurately stratify men according to risk. Recent advances in biopsy techniques, imaging, molecular genetics, and biomarkers could enable physicians to improve risk stratification at the individual level, thereby improving patient management for prostate cancer.
- Gurdarshan S. Sandhu
- Gerald L. Andriole
